RE:RE:Cannabis sector. Also, Valens just had a kitchen sink write-off quarter so maybe people expect Medipharm is next. However, Medipharm has had some big write-offs already so who knows.
Lemoyne wrote: It's simple, while most cannabis stocks posted QoQ increases lately, LABS has posted QoQ abysmal decreases. Q3 was a YoY 80%+ decrease.
I don't understand people who expect this to rise 3-5x (what most cannabis stocks did lately) without any numbers to back it. You look at this objectively from a new investor point of view and currently compare the results of the past year with other mj stock and you would not touch this with a 1000m perch. Too much uncertainty even with 550k unit shipment news (explained in other posts).
This will undoubtedly take off, with current bull wave, if Q4 and Q1 show positive increase. Until then, IF you believe this can improve (not guaranteed), you can add, if not, you can short.